Compare Stocks → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:AMSOTCMKTS:BNOEFNASDAQ:OTICNASDAQ:TTNP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$2.99$0.00$2.16▼$3.00$18.93M0.6815,180 shs47,539 shsBNOEFBionomics$0.00-43.3%$0.00$0.00▼$0.06$4.45M1.86140,299 shs22,900 shsOTICOtonomy$0.01$0.06$0.01▼$2.54$582K1.54937,525 shsN/ATTNPTitan Pharmaceuticals$7.10$7.34$5.00▼$16.60$6.49M1.3310,656 shs5,240 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services0.00%0.00%0.00%+7.63%-5.96%BNOEFBionomics0.00%0.00%0.00%0.00%-83.81%OTICOtonomy0.00%0.00%0.00%0.00%0.00%TTNPTitan Pharmaceuticals0.00%-0.84%-3.27%+15.45%-55.35%Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full storyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSAmerican Shared Hospital Services2.6789 of 5 stars0.03.00.00.01.91.73.8BNOEFBionomicsN/AN/AN/AN/AN/AN/AN/AN/AOTICOtonomyN/AN/AN/AN/AN/AN/AN/AN/ATTNPTitan PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital ServicesN/AN/AN/AN/ABNOEFBionomicsN/AN/AN/AN/AOTICOtonomyN/AN/AN/AN/ATTNPTitan PharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$21.33M0.89$1.02 per share2.94$4.17 per share0.72BNOEFBionomicsN/AN/AN/AN/AN/AN/AOTICOtonomy$130K4.48N/AN/A$0.97 per share0.01TTNPTitan Pharmaceuticals$180K35.89N/AN/A$8.82 per share0.80Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services$610K$0.0933.237.12N/A2.86%4.58%2.59%5/10/2024 (Estimated)BNOEFBionomicsN/AN/A0.00∞N/AN/AN/AN/AN/AOTICOtonomy-$51.18M-$0.77N/A∞N/AN/A-137.86%-68.50%N/ATTNPTitan Pharmaceuticals-$5.57M-$8.20N/A∞N/A-2,014.71%-165.90%-105.75%5/20/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/ABNOEFBionomicsN/AN/AN/AN/AN/AOTICOtonomyN/AN/AN/AN/AN/ATTNPTitan PharmaceuticalsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital Services0.421.901.90BNOEFBionomicsN/AN/AN/AOTICOtonomyN/A1.741.74TTNPTitan PharmaceuticalsN/A5.555.55OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%BNOEFBionomicsN/AOTICOtonomy41.23%TTNPTitan Pharmaceuticals31.49%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services30.70%BNOEFBionomicsN/AOTICOtonomy1.09%TTNPTitan Pharmaceuticals24.93%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services316.33 million4.39 millionNot OptionableBNOEFBionomicsN/A1.31 billionN/ANot OptionableOTICOtonomy5168.53 million67.78 millionOptionableTTNPTitan Pharmaceuticals4910,000686,000OptionableAMS, OTIC, BNOEF, and TTNP HeadlinesSourceHeadlineTitan Pharmaceuticals (NASDAQ:TTNP) Now Covered by StockNews.comamericanbankingnews.com - April 15 at 2:14 AMLexeo Therapeutics (NASDAQ:LXEO) and Titan Pharmaceuticals (NASDAQ:TTNP) Critical Contrastamericanbankingnews.com - April 13 at 1:30 AM2005 Nissan Titanautoblog.com - March 25 at 4:09 AMTitan Pharmaceuticals Inc (TTNP)uk.investing.com - March 2 at 9:17 AMTitan Pharmaceuticals, Inc. (TN70.F)au.finance.yahoo.com - February 20 at 2:08 PMTitan Pharmaceuticals Inc TTNPmorningstar.com - February 3 at 2:27 PMTitan Pharmaceuticals, Inc.: Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteriafinanznachrichten.de - January 26 at 9:07 PMTitan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteriafinance.yahoo.com - January 25 at 7:32 PMTitan Pharma Stock (NASDAQ:TTNP) Dividends: History, Yield and Datesbenzinga.com - January 10 at 1:05 PMTitan Pharmaceuticals: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibitscbonds.com - December 30 at 10:29 AMTitan Pharmaceuticals, Inc.: Titan Pharmaceuticals Announces Reverse Stock Split and Ratiofinanznachrichten.de - December 29 at 8:01 AMBarbie, the Titan submersible and everything else we Googled in 2023washingtonpost.com - December 28 at 8:29 PMTitan Pharmaceuticals Announces Reverse Stock Split and Ratiofinance.yahoo.com - December 28 at 8:29 PMUntitled Attack on Titan Codes (December 2023)twinfinite.net - December 27 at 3:54 PM2023 Nissan Titan XD Reviewautoblog.com - December 27 at 3:54 PMAttack on Titan Revolution Codes (December 2023)twinfinite.net - December 20 at 10:44 PMTitan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directorsfinance.yahoo.com - October 16 at 8:58 PMMore presumed human remains recovered from imploded Titan submersibletoday.com - October 14 at 10:10 AMTitan Pharmaceuticals reports $9.5M private placement of convertible preferred stockseekingalpha.com - September 18 at 11:34 AMTitan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stockfinance.yahoo.com - September 18 at 11:34 AMUnveiling Titan Pharmaceuticals (TTNP)'s Value: Is It Really Priced Right? A Comprehensive Guidefinance.yahoo.com - August 28 at 5:04 PMTitan Pharmaceuticals: Q2 Earnings Snapshotstamfordadvocate.com - August 15 at 5:27 PMTitan Pharmaceuticals (TTNP) Stock Soars on FDA Committee Treatment Approvalthestreet.com - August 13 at 6:28 PMTitan Pharmaceuticals sells certain ProNeura assets to Fedsonpharmabiz.com - July 29 at 5:54 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesCanoo, Inc. Bites the Dust: Mullen Automotive Is a Better BetApril 2, 2024 9:15 AMView Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better BetUiPath Cuts Q1 and Raises Full Year GuidanceMarch 26, 2024 7:41 AMView UiPath Cuts Q1 and Raises Full Year GuidanceNike Stock and the 30% Rally That's ExpectedMarch 22, 2024 9:45 AMView Nike Stock and the 30% Rally That's ExpectedApple: Is it Time to Reload on AI Inflection Point?March 25, 2024 6:15 AMView Apple: Is it Time to Reload on AI Inflection Point?Here’s Your Seat at the AI Table, at Half the PriceApril 10, 2024 7:45 AMView Here’s Your Seat at the AI Table, at Half the PriceAll Headlines Company DescriptionsAmerican Shared Hospital ServicesNYSEAMERICAN:AMSAmerican Shared Hospital Services provides radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.BionomicsOTCMKTS:BNOEFBionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.OtonomyNASDAQ:OTICOtonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm's product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA.Titan PharmaceuticalsNASDAQ:TTNPTitan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.